American Public Education Earnings Call Transcripts
Fiscal Year 2025
-
Delivered 4% revenue growth and 19% higher adjusted EBITDA in 2025, overcoming a government shutdown and divestiture. 2026 guidance anticipates continued margin expansion, new campus openings, and strong healthcare segment growth, with a $50M share repurchase program authorized.
-
Management outlined a plan to reach $890–$925 million in organic revenue and $182–$200 million in adjusted EBITDA by 2029, driven by new programs, global expansion, and digital transformation. RU Health Plus and APUS will focus on maximizing capacity, launching new campuses, and leveraging technology for growth and efficiency.
-
Q3 2025 results exceeded guidance, with revenue up 7% and adjusted EBITDA up 60% year-over-year. Strong enrollment growth at Rasmussen and Hondros offset APUS headwinds from a government shutdown, while cost reductions and asset sales improved cash flow and capital structure.
-
Q2 2025 results exceeded guidance with strong revenue and adjusted EBITDA growth, driven by double-digit enrollment increases at Rasmussen and Hondros. Balance sheet was strengthened through asset sales and preferred equity redemption, while full-year guidance was maintained or raised.
-
Strong momentum in military and nursing education, with lifted growth restrictions enabling campus expansion and improved financials. Consolidation of institutions aims to drive synergies by 2026, while regulatory relationships and market demand remain favorable.
-
Q1 2025 results exceeded guidance with revenue up 6.6% and adjusted EBITDA up 25% year-over-year. Full-year adjusted EBITDA and net income guidance were raised, while Graduate School USA remains a drag due to federal budget uncertainty. Institutional consolidation and preferred stock redemption are expected to drive further profitability.
Fiscal Year 2024
-
Q4 and full-year 2024 results exceeded guidance, with strong revenue and EBITDA growth across all segments. 2025 guidance projects continued gains, supported by institutional consolidation, cost actions, and robust enrollment trends, especially in nursing and online education.
-
Q3 2024 saw 1.5% revenue growth to $153M, with adjusted EBITDA above guidance and net income at the high end. Rasmussen and Hondros posted strong enrollment gains, and full-year revenue and EBITDA guidance were raised. Nursing and military/veteran education demand remains strong.
-
Q2 2024 saw 3.9% revenue growth and a 24% increase in adjusted EBITDA, with Rasmussen posting its first positive year-over-year enrollment and revenue since acquisition. Full-year guidance is unchanged, and margin improvements are expected as Rasmussen turns profitable in Q4.
-
The conference highlighted strong financial performance, operational improvements, and a robust market position in military and nursing education. Lifting of growth restrictions and continued expansion are expected to drive further growth and margin improvement.